Literature DB >> 30207179

Pazopanib in relapsed osteosarcoma patients: report on 15 cases.

Alessandra Longhi1, Anna Paioli1, Emanuela Palmerini1, Marilena Cesari1, Massimo E Abate1, Elisabetta Setola1, Paolo Spinnato2, Davide Donati3, Ivar Hompland4, Kjetil Boye4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30207179     DOI： 10.1080/0284186X.2018.1503714

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  21 in total

1.  Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations.

Authors:  Yoshiyuki Suehara; Deepu Alex; Anita Bowman; Sumit Middha; Ahmet Zehir; Debyani Chakravarty; Lu Wang; George Jour; Khedoudja Nafa; Takuo Hayashi; Achim A Jungbluth; Denise Frosina; Emily Slotkin; Neerav Shukla; Paul Meyers; John H Healey; Meera Hameed; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

2.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

3.  The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study.

Authors:  Feifei Sun; Suying Lu; Zijun Zhen; Jia Zhu; Juan Wang; Junting Huang; Yu Zhang; Hui Li; Ruiqing Cai; Meiling Liu; Liuhong Wu; Xiaofei Sun; Yizhuo Zhang
Journal:  Cancer Manag Res       Date:  2020-07-22       Impact factor: 3.989

Review 4.  Advances in the Management of Pediatric Sarcomas.

Authors:  Fiorela N Hernandez Tejada; Alejandro Zamudio; Mario L Marques-Piubelli; Branko Cuglievan; Douglas Harrison
Journal:  Curr Oncol Rep       Date:  2020-11-16       Impact factor: 5.075

Review 5.  Update on Osteosarcoma.

Authors:  Rebekah Belayneh; Mitchell S Fourman; Sumail Bhogal; Kurt R Weiss
Journal:  Curr Oncol Rep       Date:  2021-04-21       Impact factor: 5.075

Review 6.  Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma.

Authors:  Marissa A Just; David Van Mater; Lars M Wagner
Journal:  Pediatr Blood Cancer       Date:  2021-04-24       Impact factor: 3.838

Review 7.  The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.

Authors:  Isabelle Corre; Franck Verrecchia; Vincent Crenn; Francoise Redini; Valérie Trichet
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

8.  Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience.

Authors:  Ninna Aggerholm-Pedersen; Phillip Rossen; Hanne Rose; Akmal Safwat
Journal:  Transl Oncol       Date:  2019-12-23       Impact factor: 4.243

9.  Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Authors:  Kjetil Boye; Alessandra Longhi; Tormod Guren; Susanne Lorenz; Stine Næss; Michela Pierini; Ingeborg Taksdal; Ingvild Lobmaier; Marilena Cesari; Anna Paioli; Ayca M Løndalen; Elisabetta Setola; Ivar Hompland; Leonardo A Meza-Zepeda; Kirsten Sundby Hall; Emanuela Palmerini
Journal:  Cancer Immunol Immunother       Date:  2021-02-12       Impact factor: 6.968

10.  223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy.

Authors:  Pete M Anderson; Jacob Scott; Shireen Parsai; Stacey Zahler; Sarah Worley; Sankaran Shrikanthan; Vivek Subbiah; Erin Murphy
Journal:  ESMO Open       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.